Winner Medical(SZ:300888) Zhong Guo Zheng Quan Bao·2025-10-22 22:17Core Viewpoint - The company, Steady Medical, is transitioning from product export to brand export, aiming to establish itself as a leading global health enterprise through high-quality products and operational excellence [1][4][6]. Group 1: Company History and Development - Founded in 1991 by Li Jianquan, Steady Medical initially focused on medical dressings and later launched the consumer brand "Cotton Era" in 2009, marking its entry into the consumer goods market [1][2]. - The company faced significant challenges in its early years, including nearly 200 million yuan in cumulative losses over the first four years of Cotton Era's establishment, due to high costs and consumer unfamiliarity with cotton products [3][4]. - Steady Medical's commitment to quality over cost has been a cornerstone of its growth, leading to its emergence as a top exporter of medical dressings in China [2][3]. Group 2: Business Model and Strategy - The company operates a dual business model focusing on both medical and consumer products, leveraging the same supply chain and technology standards for synergy [4][5]. - Steady Medical emphasizes innovation and high-quality product development, with a vision of "Cotton Changing the World," and has established itself as a leader in the cotton towel market [4][5]. - The company has invested 2.062 billion yuan in R&D from 2020 to mid-2025, establishing a complete innovation cycle that has contributed to significant revenue growth [5][6]. Group 3: Financial Performance - In the first half of 2025, Steady Medical reported revenues of 5.296 billion yuan, a year-on-year increase of 31.31%, with net profits of 492 million yuan, up 28.07% [5][6]. - The medical segment achieved revenues of 2.52 billion yuan, growing by 46.4%, while Cotton Era generated 2.75 billion yuan, reflecting a 20.3% increase [5][6]. Group 4: Global Expansion and Acquisitions - The company is shifting towards brand export, highlighted by its acquisition of 75.2% of the U.S. medical consumables company GRI for 120 million USD, which is a key step in its globalization strategy [5][6]. - Steady Medical's overseas sales channels generated 1.43 billion yuan in revenue in the first half of 2025, marking an 81.3% increase, with products sold in over 110 countries [6][7]. - The company plans to transition 90% of its overseas medical business to its own brand, moving away from OEM production, while Cotton Era aims to solidify its domestic presence before expanding internationally [6][7].